| Biomarker ID | 1274 |
| PMID | 24386364 |
| Year | 2013 |
| Biomarker | BTF3 |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in PCa (2.5 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: RPL19, RPL18A, RPS18, RPL23, RPS6 |
| Experiment | Benign Vs Malignant |
| Type of Biomarker | Diagnostic |
| Cohort | 41 pair matched (Benign And Malignant) were analysed in the study |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.74 |
| Accuracy | NA |
| Level Of Significance | p<0.0001 |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |